Clinical Benefits of Long-Acting Injectable Antipsychotics
In a recent publication in the journal Schizophrenia, researchers conducted an observational mirror-image study (STAR Network Depot Study) that included 261 long-acting injectable (LAI) antipsychotics–naive participants aged at least 18 years between 2015 and 2018. Based on their results, the authors indicated a shorter illness duration and lower attitude and adherence scores were  observed in LAI discontinuers. Read more.

Poll Highlights Anxiety Levels, Mental Health Among Americans
A recent annual poll revealed that 70% of U.S. adults felt anxious or extremely anxious about keeping themselves or their families safe, and that while the number is lower than reported when compared with the early stages of the COVID-19 pandemic in 2020, it is 6% greater than in the past 2 years. Learn more about the results of this poll.

Guidelines Updated for Depression, Anxiety in Adult Cancer Survivors
In a recent publication, researchers provided information from a multidisciplinary expert panel, which updated the American Society of Clinical Oncology guidelines on the management of anxiety and depression in adult cancer survivors. Find out what the American Society of Clinical Oncology recommended to oncology professionals and other healthcare providers involved in the care of adult cancer survivors